NCT03177187 2024-09-26
ACE
Institute of Cancer Research, United Kingdom
Phase 1/2 Terminated
Clinical Trials
5 trialsNCT04458311 2024-04-25
ACTIon
Institute of Cancer Research, United Kingdom
Phase 1/2 Terminated
NCT03752099 2023-09-26
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
Veru Inc.
Phase 1/2 Terminated
NCT03658447 2023-07-28
PRINCE
Peter MacCallum Cancer Centre, Australia
Phase 1/2 Completed
NCT04486937 2020-07-27
mCRPC
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 1/2 Unknown